1284 / 1840
•
30 patients previously
irradiated by EBRT
•
36 sites of disease
treated with HDR-IBT
•
Mean tumor dose 34 Gy
(18-48 Gy)
•
Bid fractions (300/400
cGy)
•
1 year-LC: 69%
•
2-years DFS: 45%
•
2-years OS: 37%
•
G3/G4 toxicity: 16%